Ginkgo Bioworks Holdings, Inc.
NYSE:DNABiotechnology
Healthcare
$8.44 +3.04%
+$0.26 today
- Market cap
- $547.12M
- Beta
- 1.80
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$5.11
52W Low $5.37High $17.58
Volume 2.36M
Average 1.24M
Price history
Ginkgo Bioworks Holdings, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+6.70%
Period high
$14.98
Period low
$5.48
Latest
$8.44
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Oct 29, 2026 | Oct 29, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Sep 16, 2026 | Sep 16, 2026 | |
| 4 | Aug 25, 2026 | Aug 25, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Jul 30, 2026 | Jul 30, 2026 | |
| 4 | Jul 30, 2026 | Jul 30, 2026 | |
| 8-K | Jul 30, 2026 | Jul 30, 2026 |
Competitors
Who does Ginkgo Bioworks Holdings, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about DNA's filings, answered from its disclosures.
What is the latest DNA filing?
The latest filing shown is 10-Q dated Nov 9, 2026.
How many recent filings does DNA have?
Intrinsic Alpha currently shows 20 recent filings for DNA.
Continue the stock analysis
Jump to another research area for this company.